BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33460910)

  • 1. A perspective on the standards describing mass spectrometry-based metabolic phenotyping (metabolomics/metabonomics) studies in publications.
    Wilson ID; Theodoridis G; Virgiliou C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1164():122515. PubMed ID: 33460910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissemination and analysis of the quality assurance (QA) and quality control (QC) practices of LC-MS based untargeted metabolomics practitioners.
    Evans AM; O'Donovan C; Playdon M; Beecher C; Beger RD; Bowden JA; Broadhurst D; Clish CB; Dasari S; Dunn WB; Griffin JL; Hartung T; Hsu PC; Huan T; Jans J; Jones CM; Kachman M; Kleensang A; Lewis MR; Monge ME; Mosley JD; Taylor E; Tayyari F; Theodoridis G; Torta F; Ubhi BK; Vuckovic D;
    Metabolomics; 2020 Oct; 16(10):113. PubMed ID: 33044703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolite Measurement: Pitfalls to Avoid and Practices to Follow.
    Lu W; Su X; Klein MS; Lewis IA; Fiehn O; Rabinowitz JD
    Annu Rev Biochem; 2017 Jun; 86():277-304. PubMed ID: 28654323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC-MS-based holistic metabolic profiling. Problems, limitations, advantages, and future perspectives.
    Gika HG; Wilson ID; Theodoridis GA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():1-6. PubMed ID: 24618029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality assurance and quality control reporting in untargeted metabolic phenotyping: mQACC recommendations for analytical quality management.
    Kirwan JA; Gika H; Beger RD; Bearden D; Dunn WB; Goodacre R; Theodoridis G; Witting M; Yu LR; Wilson ID;
    Metabolomics; 2022 Aug; 18(9):70. PubMed ID: 36029375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of Experimental Methods and Study Design in Metabolomics, and Statistical and Pathway Considerations.
    Barnes S
    Methods Mol Biol; 2020; 2104():1-10. PubMed ID: 31953809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current practice of liquid chromatography-mass spectrometry in metabolomics and metabonomics.
    Gika HG; Theodoridis GA; Plumb RS; Wilson ID
    J Pharm Biomed Anal; 2014 Jan; 87():12-25. PubMed ID: 23916607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing and Performing Targeted Multi-residue Analysis for Lipid Mediators and Fatty Acids in Small Clinical Plasma Samples.
    Pedersen TL; Newman JW
    Methods Mol Biol; 2018; 1730():175-212. PubMed ID: 29363074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable isotope coded derivatizing reagents as internal standards in metabolite profiling.
    Bruheim P; Kvitvang HF; Villas-Boas SG
    J Chromatogr A; 2013 Jun; 1296():196-203. PubMed ID: 23628173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixture model normalization for non-targeted gas chromatography/mass spectrometry metabolomics data.
    Reisetter AC; Muehlbauer MJ; Bain JR; Nodzenski M; Stevens RD; Ilkayeva O; Metzger BE; Newgard CB; Lowe WL; Scholtens DM
    BMC Bioinformatics; 2017 Feb; 18(1):84. PubMed ID: 28153035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry-based metabolomics: a guide for annotation, quantification and best reporting practices.
    Alseekh S; Aharoni A; Brotman Y; Contrepois K; D'Auria J; Ewald J; C Ewald J; Fraser PD; Giavalisco P; Hall RD; Heinemann M; Link H; Luo J; Neumann S; Nielsen J; Perez de Souza L; Saito K; Sauer U; Schroeder FC; Schuster S; Siuzdak G; Skirycz A; Sumner LW; Snyder MP; Tang H; Tohge T; Wang Y; Wen W; Wu S; Xu G; Zamboni N; Fernie AR
    Nat Methods; 2021 Jul; 18(7):747-756. PubMed ID: 34239102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolite profiling of a NIST Standard Reference Material for human plasma (SRM 1950): GC-MS, LC-MS, NMR, and clinical laboratory analyses, libraries, and web-based resources.
    Simón-Manso Y; Lowenthal MS; Kilpatrick LE; Sampson ML; Telu KH; Rudnick PA; Mallard WG; Bearden DW; Schock TB; Tchekhovskoi DV; Blonder N; Yan X; Liang Y; Zheng Y; Wallace WE; Neta P; Phinney KW; Remaley AT; Stein SE
    Anal Chem; 2013 Dec; 85(24):11725-31. PubMed ID: 24147600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomic Strategies Involving Mass Spectrometry Combined with Liquid and Gas Chromatography.
    Lopes AS; Cruz EC; Sussulini A; Klassen A
    Adv Exp Med Biol; 2017; 965():77-98. PubMed ID: 28132177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Current Practice Adhering to Guidelines Proposed for Metabolite Identification in LC-MS Untargeted Metabolomics? A Meta-Analysis of the Literature.
    Kodra D; Pousinis P; Vorkas PA; Kademoglou K; Liapikos T; Pechlivanis A; Virgiliou C; Wilson ID; Gika H; Theodoridis G
    J Proteome Res; 2022 Mar; 21(3):590-598. PubMed ID: 34928621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics by Gas Chromatography-Mass Spectrometry: Combined Targeted and Untargeted Profiling.
    Fiehn O
    Curr Protoc Mol Biol; 2016 Apr; 114():30.4.1-30.4.32. PubMed ID: 27038389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics 2022 workshop report: state of QA/QC best practices in LC-MS-based untargeted metabolomics, informed through mQACC community engagement initiatives.
    Dunn WB; Kuligowski J; Lewis M; Mosley JD; Schock T; Ulmer Holland C; Zanetti KA; Vuckovic D;
    Metabolomics; 2023 Nov; 19(11):93. PubMed ID: 37940740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reference materials for MS-based untargeted metabolomics and lipidomics: a review by the metabolomics quality assurance and quality control consortium (mQACC).
    Lippa KA; Aristizabal-Henao JJ; Beger RD; Bowden JA; Broeckling C; Beecher C; Clay Davis W; Dunn WB; Flores R; Goodacre R; Gouveia GJ; Harms AC; Hartung T; Jones CM; Lewis MR; Ntai I; Percy AJ; Raftery D; Schock TB; Sun J; Theodoridis G; Tayyari F; Torta F; Ulmer CZ; Wilson I; Ubhi BK
    Metabolomics; 2022 Apr; 18(4):24. PubMed ID: 35397018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Untargeted LC/MS-based metabolic phenotyping (metabonomics/metabolomics): The state of the art.
    Gika H; Virgiliou C; Theodoridis G; Plumb RS; Wilson ID
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jun; 1117():136-147. PubMed ID: 31009899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of mass calibration gaps in liquid chromatography-mass spectrometry metabolomics data.
    Benton HP; Want EJ; Ebbels TM
    Bioinformatics; 2010 Oct; 26(19):2488-9. PubMed ID: 20671148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of gas chromatography/isotope ratio mass spectrometry and liquid chromatography/isotope ratio mass spectrometry for carbon stable-isotope analysis of carbohydrates.
    Moerdijk-Poortvliet TC; Schierbeek H; Houtekamer M; van Engeland T; Derrien D; Stal LJ; Boschker HT
    Rapid Commun Mass Spectrom; 2015 Jul; 29(13):1205-14. PubMed ID: 26395604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.